Process for producing a vasal fibrinolytic active principle and

Details Process for producing a vasal fibrinolytic active principle and Process for producing a vasal fibrinolytic active principle and

1982-04-07

1984-09-11

Shapiro, Lionel M.

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Hydrolase

435212, C12N 964, C12N 948

Patent

active

044710534

ABSTRACT:
A natural active principle enzymatic in type, called angiokinase, is obtained with an extraction procedure starting from mammalian connective tissue, such as from cattle and the like. The active principle comprises a new drug for the prophylaxis and treatment of all symptoms of abnormal fibrin formation and thrombus formation in various sites and localizations, such as atherosclerotic diseases and diabetic retinopathy, as well as thrombosis and thromboembolisms.

REFERENCES:
patent: 3998847 (1976-12-01), Reich et al.
patent: 4245051 (1981-01-01), Eder et al.
patent: 4374830 (1983-02-01), Schneider
patent: 4381346 (1983-04-01), Husain et al.

Affiliated with

Also associated with

Rating

Process for producing a vasal fibrinolytic active principle and does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for producing a vasal fibrinolytic active principle and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for producing a vasal fibrinolytic active principle and will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1195022